Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
-
Hydreight Reports Corporate Update and Ranks #25 on Deloitte’s 2025 Technology Fast 50™
-
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit
-
AIM ImmunoTech to Attend the 2025 Maxim Growth Summit
-
Empery Digital Releases New Investor Presentation
-
Maxim Group Downgrades Cryo-Cell International, Inc. (CCEL) to Hold
-
Perfect Corp to Present at Spartan Capital Securities' Second Annual Investor Conference
-
Perfect Corp to Present at Spartan Capital Securities' Second Annual Investor Conference
-
Castellum, Inc. to Attend the 2025 Maxim Growth Summit
-
Volatus Aerospace to Attend the 2025 Maxim Growth Summit
-
DeFi Technologies to Attend the 2025 Maxim Growth Summit
-
Rani Therapeutics raises $60.3 million in oversubscribed private placement
-
Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
-
HCW Biologics to Participate in the 2025 Maxim Growth Summit
-
Edible Garden Enters into Warrant Exercise Transaction for $4.2 Million in Gross Proceeds
-
Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit
-
AmpliTech Group To Attend The 2025 MAXIM Growth Summit
-
Ur-Energy Participates in the 2025 Maxim Growth Summit in New York
-
NioCorp closes $150.2 million share offering at $9.34 per share
-
NioCorp Announces Closing of $150.2 Million Registered Direct Offering of Common Shares Priced At-the-Market
-
SEALSQ prices $200 million stock and warrant offering at premium
-
SEALSQ prices $200 million equity offering at premium to market
-
SEALSQ Announces Pricing of $200.0 Million Registered Direct Offering & Concurrent Private Placement of Ordinary Shares and Warrants
-
SEALSQ Announces Pricing of $200.0 Million Registered Direct Offering & Concurrent Private Placement of Ordinary Shares and Warrants
-
BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit
-
American Resources Corporation prices $40 million private placement
-
American Resources Corporation Announces Pricing of $40.0 Million Private Placement of Common Stock
-
Alpha Cognition, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference
-
Aura Systems Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference
-
Aura Systems Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference
-
Genasys Inc. to Participate in 2025 Maxim Growth Summit
-
Alpha Cognition, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference
-
CERo Therapeutics to Participate in Stem Cell Therapy Panel at the Maxim Growth Summit 2025
-
CareCloud to Present at the 2025 Maxim Growth Summit
-
Arrive AI to Share AI-Powered Growth Story and Meet with Investors at Maxim Growth Summit
-
DealFlow Events to Host The PIPEs Conference on November 12-13, 2025
-
Dogwood Therapeutics to Participate at the Maxim Growth Summit 2025
-
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
-
Roadzen to Present at October Investor Conferences in New York
-
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit
-
American Resources Corporation prices $33.7 million private placement
-
American Resources Corporation Announces Pricing of $33.7 Million Private Placement of Common Stock
-
NioCorp prices $150.2 million share offering at $9.34 per share
-
NioCorp Announces Pricing of $150.2 Million Registered Direct Offering of Common Shares Priced At-the-Market
-
Maxim Group Downgrades SWK Holdings (SWKH) to Hold
-
Quoin Pharmaceuticals raises up to $104.5 million in private placement
-
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million
-
DDC Enterprise raises $124 million in equity financing round
-
DDC Enterprise Raises $124 Million with Participation from PAG Pegasus Fund and Mulana Investment — Founder Norma Chu Joins Round with $3 Million Investment to Advance Bitcoin Treasury Strategy
-
OS Therapies to Participate in Fall 2025 Conferences and Events

